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Abstract
The aim of the present study was to provide a list of psychological variables likely to explain cannabis abuse 
among adolescents and young adults based on the following psychological risk factors: anxiety, depression, difficulty 
in describing feelings, difficulty in identifying feelings, and external oriented thought. The analysis was based on the 
multiple logistic regression technique; the step-wise procedure showed that only anxiety, depression, and difficulty in 
describing feelings were retained in the final model. Following this, additive versus interactive models under different 
assumptions between the three independent variables were also assessed. The key findings of this study are 
twofold: (a) anxiety was revealed to be the primary risk factor for cannabis abuse and (b) no interaction between the 
aforementioned factors proved to be significantly informative in explaining high risk cannabis abuse. Findings were 
discussed in the context of the current knowledge of the relationship between anxious and depressive symptoms and 
higher risk of substance abuse and dependence.
Keywords: Cannabis abuse; Anxiety; Depression; Alexithymia; 
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Introduction
Given their capacity to actively operate on our central nervous 
system, psychoactive drugs are known to alter behavior, cognition, 
mood, and consciousness. The abuse of these substances can lead to 
psychological addiction and vice versa as a result of the stimulation 
of the brain’s dopaminergic reward system. Among the illicit drugs, 
cannabis is one of the most used substances by teenagers and young 
adults. Cannabis use, abuse, and dependence are frequently seen in 
teenagers [1,2] and young adults [3,4]. Cannabis is the most widely 
used illicit drug in Europe where consumption its use has significantly 
increased since 2011. 
According to the recent report of the “European Monitoring Center 
for Drugs and Drug Addiction” [5], France is among the top ranked 
countries in cannabis use. In addition, cannabis is considered the most 
consumed illegal substance among very young people (13-16 years). 
Indeed, 50% of 17-year-old French teenagers have used cannabis at 
least once, and 7.3% are regular cannabis users. 42% among the 18-64 
year-old have already experienced cannabis use and 11% report having 
tried it at least once during the last year. Another interesting fact is 
that 2.2% are identified as users at high risk of abuse or dependence. 
Finally, 17% of the18-25 year-old people have smoked cannabis in the 
past month, 8% are regular users and 4% are users on a daily basis. 
Men were reported to be significantly more likely to use cannabis than 
women and this gap increases with higher levels of use.
Many studies have provided evidence for the increase in risk of 
physical disease associated with regular use of cannabis [6,7]. Recent 
studies have shown that the endocannabinoid system is highly involved 
in many neurobiological substrates underlying drug addiction [8]. 
More recently [1], showed that Delta(9)-tetra-hydrocannabinol, which 
is the psychoactive component in cannabis, can have a long-lasting 
effect on brain functions despite its minimal neurological variations. 
The damaging effects of a single exposure to cannabis on cognitive 
functions include: attention, memory, executive function deficits [9,10] 
and auditory and visual information processing dysfunctions [11,12].
Note: The DSM-IV differentiates between substance dependence 
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and substance abuse. According to the DSM-IV-TR, substance abuse 
can be mainly diagnosed based on the following symptoms occurring 
at any time in the same 12-month period: 1. recurrent substance use 
resulting in a failure to fulfill major role obligations at work, school, 
or home, 2. recurrent substance use in situations in which it is 
physically hazardous, 3. recurrent substance-related legal problems, 4. 
continued substance use despite having persistent or recurrent social 
or interpersonal problems caused or exacerbated by the effects of the 
substance, 5. the symptoms have never met the criteria for substance 
dependence for this class of substance [13].
The involvement of cannabis use in various psychiatric disorders 
has been established in many studies, including in schizophrenia 
[14,15], mood disorders [16-19], depression [20-22], anxiety [6] and 
behavioral disorders among young people. Brook [23,24] examined 
the association between psychosocial risk and protective factors and 
cannabis use disorders. They showed, among other things, that the 
increase in psychological symptoms (through personality attributes) is 
associated with an increased risk for cannabis use disorders.
Cannabis abuse, anxiety, and depression
The comorbidity between cannabis dependence/abuse and the 
DSM-III-R Axis I psychiatric diagnosis has been reported to be 
reliable. For example [25], found that 83% of their cannabis-dependent 
participants and 46% of their cannabis abusers met the DSM-III-R first 
psychiatric diagnosis axis. 
Page 2 of 7
Volume 2 • Issue 1 • 1000107
Clin Exp Psychol
ISSN: 2471-2701 an open access journal
Citation: Bejaoui M, Marzouki Y  (2015)  Potential Psychological Factors Associated with High Risk for Cannabis Abuse: Evidence from Multiple Logistic 
Regression. Clin Exp Psychol 2: 107. doi:10.4172/2471-2701.1000107
performance, and causes relationship, family and social problems [48];
-at forensic level, problems such as road traffic accidents [49] and 
delinquency. 
All these health problems tend to increase as a function of the 
substance use [50]. 
The major focus in studying addictive behavior concerns drug and 
alcohol misuse. Despite a large amount of studies being focused on 
medical, epidemiological, forensic and also cognitive aspects that result 
from cannabis use, very few studies have examined the contribution of 
the psychological factors that lead to cannabis abuse or dependence. 
Moreover, when cannabis use disorders were studied in relation to 
psychiatric disorders, comorbidity with schizophrenia was found. 
On the other hand, studies have already shown that addicted 
individuals significantly demonstrate increased depression and more 
anxiety symptoms relative to controls [51]. Furthermore, addicted 
individuals score high on standard alexithymia scales [52].  
One common feature about the occurrence of psychological factors 
and addictive behavior in the mainstream of the studies cited above is 
that these factors are usually concomitant which can support the idea 
of comorbidity between psychological factors and addictive behavior. 
Accordingly, each of these psychological factors (anxiety, depression 
and alexithymia) must be tested within one regression model in order 
to individually evaluate their weights in estimating the high risk for 
cannabis abuse. Unlike previous studies that separately investigated the 
different roles of the aforementioned psychological factors of high risk 
for cannabis abuse, the present research used an experimental approach 
that examined their additive and interactive effects within a statistical 
regression framework.
Method
Participants
Initial sample of 268 students (44 males, mean age = 23 years, SD = 
6.4; 224 females, mean age = 22 years, SD = 5.2) from the University of 
Provence volunteered to participate in our study. They were presented 
with a series of self-report questionnaires including: CAGE-Alcohol 
(for alcohol dependence), CAST (for cannabis abuse) and Fagerström 
(for tobacco dependence). Only participants with cannabis abuse either 
exclusively or associated with alcohol were retained (Table 1). Based 
on their final scores on the three questionnaires, only 35 participants 
(men = 9, mean age = 21, SD= 1.26 ; women= 26, mean age = 21, SD 
=2.28) were assigned to the experimental group (16 were exclusively 
participants with high risk for cannabis abuse) whereas 58  participants 
formed the control group (no abuse/dependence of any of the three 
substances) (men =10, mean age =25, SD=3.37;  women=21, mean age 
= 21, SD =2.9). All participants filled out a consent form prior to their 
participation.
Note: The other 175 participants were excluded from this study 
because they do not consume cannabis, however they can be tobacco or 
alcohol consumers. In addition, the 58 control subjects do not consume 
any of the following three substances: cannabis, alcohol and tobacco.
Material 
Series of psychological screening tests was administrated for each 
participant in the following order:
The Cannabis Abuse Screening Test (CAST): This test was developed 
at the French Monitoring Center for Drugs and Drug Addiction (2107) 
Depression and anxiety have been reported to occur within addicted 
populations, which has led some researchers to acknowledge these 
factors as significant potential risk factors (comment 14) for addiction. 
Anxious and depressive disorders are common in adolescents and 
young adults [26] and are associated with a higher risk of substance use 
disorders [27] including cannabis use [28-30]. 
Hayatbakhsh [16] found that frequent cannabis use is linked to 
higher anxiety and depression in young adults, even in the absence 
of other illicit substance use. A follow-up longitudinal study [17] 
concluded that 22% of patients with regular Cannabis Use Disorder 
(CUD) had pre-existing anxiety disorders and 37% had pre-existing 
affective disorders. According to various studies, increasing cannabis 
use is associated with increasing levels of depression [19,20]. Moreover 
cannabis use has also been correlated to depressive disorders [31] 
anxiety symptoms [6,25,32,33] and anxiety vulnerability [34,35].
Cannabis abuse and alexithymia
Sifneos [36] coined the concept of alexithymia and defined it as 
an absence of words to describe emotions and also the incapacity to 
recognize emotions. Despite the fact that alexithymia was originally 
defined as a personality trait, it is currently considered as a state and a 
coping strategy. When facing stressful situations, alexithymia may play 
the role of a coping strategy in order to manage the anxiety generated by 
these situations. It is a state and a defensive style operating in daily life 
situations that overtake our adaptation capacities (e.g., a state of post-
traumatic stress) suggested considering alexithymia as an adaptation of 
the cognitive system in the presence of constraining situations.
Contrary to the above mentioned disorders, alexithymia is not 
considered by the DSM to be mental disorder [13] even though it can 
be considered a risk factor and can be clinically associated with some 
somatic, neurological, psychiatric disorders as well as addiction [37-
41]. Moreover, alexithymia can even be detected among healthy people. 
In fact, according to [42], 21% of healthy individuals showed high 
scores of alexithymia as opposed to 41% of drug addicted individuals 
and 63% of alcoholic individuals [43] provided an extensive empirical 
review of major studies that focused on abuse/dependence and several 
associated psychological factors. They found that 40 to 70% of substance 
abusers were also alexithymic [25,44] reported that 30% of young 
cannabis abusers/dependent were alexithymic, based on the 20-item 
Toronto Alexithymia Scale [TAS-20]. In a multimethod alexithymia 
assessment of 87 adolescents and young adults with a cannabis use 
disorder [45], found that 35.6 % were alexithymic. Additionally, they 
used the Beck Depression Inventory (BDI) cutoff score to evaluate 
depressive symptoms: 2% of individuals presented severe depression, 
22% moderate, and 36% mild depressive symptoms. Only these few 
studies had reported the prevalence of alexithymia among participants 
with high risk for cannabis abuse.
The present study
In the French context, the regular use of cannabis and more 
importantly its abuse (i.e., dependence) represent a major public health 
concern that includes: 
-at the physical level: cancers of the lung and upper aerodigestive 
tract, diseases of the circulatory and respiratory system [46];
-at the mental level: anxiety disorders, panic attacks, 
depersonalization disorder, hallucinations, aggression and temporo-
spatial disorientation, schizophrenia [47];
-at the social level: decrease of the academic and professional 
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Analyses
In presence of a binary outcome, the Generalized Linear Model 
is the alternative statistical technique to be applied given the absence 
of basic normal distribution requirements of the dependant variable 
[59]. Logistic regression is the appropriate method to use to explain 
a dichotomous outcome by continuous regressors. To do this, the 
multiple logistic regression technique was used. This technique has 
become a standard method in many recent clinical and epidemiological 
studies [60]. Additional analyses including: (a) regression diagnosis 
with stepwise procedure (b) additive versus multiplicative models 
comparisons and (c) odds ratios (ORs) to evaluate psychological risk 
factors associated with cannabis abuse.
Results
Table 2 gives a description of the standard distribution statistics for 
the five psychological risk factors for all participants. Figure 1 provided 
the distribution for each factor against groups (participants with high 
risk vs. control). Anxiety, depression, and difficulty identifying feelings 
showed the most segregation between abusers and control participants 
whereas externally-oriented thinking presented a significant overlap 
between the two groups. Difficulty describing feelings showed a big 
inter-subject variability, though limited only to the case of participants 
with high risk for cannabis abuse. For depression, results show that the 
average of participants with high risk of cannabis abuse seems to fall 
around 11 (mild to low moderate) while the mean for the participants 
with no high risk of cannabis abuse is in the normal range. A more 
interesting result appears for anxiety, where participants with high risk 
of cannabis abuse appears to have a bi-modal distribution with respect 
to anxiety, with the upper part of the distribution having scores in the 
mild to moderate range and the lower part of the distribution clearly in 
the normal range. All of the non-abusers are in the normal range.
Multiple regression analysis
A multiple logistic regression analysis was conducted on our data 
with cannabis abuse (0 = control vs. 1 = abusers) as a binary outcome and 
anxiety, depression, difficulty describing feelings, difficulty identifying 
feelings and externally oriented thinking as five continuous regressors. 
Table 3 presents the estimated parameters of the model and the odds 
ratio for each factor. The results show that the only significant factor 
is anxiety (p<.01) and depression (p<.05), while difficulty-describing 
feelings was not significant (p=.092). 
For a one unit in the anxiety subscale, the log odds of being 
participants with high risk for cannabis abuse increases by 1.30. 
According to the odds-ratio, obtained by exponentiating the regression 
coefficients, cannabis abuse is 3.7 times more likely when the person is 
anxious, 3.5 times more likely when the person is depressive and 1.3 
times more likely when a person shows signs of difficulty describing 
feelings. 
Stepwise procedure and model selection 
Since not all factors showed a significant effect on the outcome, it 
and is a six-item screening test for cannabis abuse in general population. 
The CAST estimates the risk of abuse of cannabis in adolescence and 
early adulthood, and is used by the French Interdepartmental Mission 
for the fight against drugs and drug addiction (MILDT) [53], performed 
a test validation using a French sample of 1711 individuals aged from 
14 to 22 in order to determine optimum thresholds for the CAST. 
Moreover, the CAST has showed a high internal consistency (α=.74) 
and a very high sensitivity and specificity (.93 and .81 respectively). The 
measure allows for two rating procedures: (a) a binary response rating 
and (b) a graduated rating (never, rarely, sometimes, quite often, and 
very often). In the first procedure, an overall score of 1 or 2 indicates 
a low level risk of abuse, a score of 3 indicates a moderate level and a 
score of 4 or more indicates a high level of risk abuse. The following two 
procedures were both used in the present study:
Hospital Anxiety and Depression Scale (HADS): The HADS is a 
self-report rating scale developed by [54] for anxiety and depression 
evaluation in hospital general medical outpatients. The HADS has been 
extensively used in primary care and in general population surveys. 
Fourteen items (7 for the anxiety subscale and 7 for the depression 
subscale) are presented in random order. Each item is scored on a four-
point scale from 0 (not present) to 3 (considerable). Subscale scores are 
divided into 4 ranges: normal (0-7), mild (8-10), moderate (11-15) and 
severe (16-21). The French version of the HADS was validated by [55].
Toronto Alexithymia Scale (TAS-20): The TAS-20 is a 20-item self-
report rating scale developed by [56]. The current version of TAS-20 
has three subscales: i) difficulty describing feelings subscale (DDF, five 
items), difficulty identifying feelings subscale (DIF, seven items) and 
externally-oriented thinking subscale (EOT, eight items). Items are 
rated using a five-point Likert scale from 1 (strongly disagree) and 5 
(strongly agree). The total alexithymia score is the sum of responses to 
all 20 items, while the score for each subscale is the sum of the responses 
to items for that subscale. The TAS-20 is based on a cutoff scoring: a 
score from 0 to 51 points indicates non-alexithymia, a score from 52 
to 60 indicates possible alexithymia and a score from 61 to 100 points 
indicates alexithymia. French validation was performed by [57]. 
Note: According to a recent psychometric study on the French 
version of the CAST [58], used several indicators to identify the optimal 
scores mainly: the sensitivity measure that reflects the proportion of 
true positives (i.e., those screened positive with the CAST when having 
a clinical diagnosis) and the specificity indicates the proportion of true 
negatives (i.e., those with a negative screening result when having no 
diagnosis). In order to determine the best balance between sensitivity 
and specificity, they calculated the Youden index Y as an indicator of 
the ability of the CAST to discriminate between individuals with and 
without a diagnosis.
Cannabis abuse is the dependent variable and was treated as 
a binary outcome as follows: 0 indicates participants with no high 
risk for cannabis abuse, 1 indicates participants with high risk for 
cannabis abuse. The following five continuous independent variables 
were considered: Anxiety, Depression, difficulty describing feelings, 
difficulty identifying feelings and externally-oriented thinking. 
N Age Gender CAST score Cannabis amount on a weekly basis
Cannabis amount on a 
daily basis
Addicted participants 
(Experimental group)
Cannabis only n = 16 21 13 females 15.56 6 times 10 times
Cannabis
+
Alcohol
n =19 21 13 females 18.48 5 times 14 times
Control group n =58 21 48 females 6.75 - -
Table 1: Participants’ characteristics.
Page 4 of 7
Volume 2 • Issue 1 • 1000107
Clin Exp Psychol
ISSN: 2471-2701 an open access journal
Citation: Bejaoui M, Marzouki Y  (2015)  Potential Psychological Factors Associated with High Risk for Cannabis Abuse: Evidence from Multiple Logistic 
Regression. Clin Exp Psychol 2: 107. doi:10.4172/2471-2701.1000107
Discussion
Using a multiple logistic regression model, five variables were 
tested to investigate cannabis abuse: anxiety, depression, difficulty 
in describing feelings, difficulty in identifying feelings and external 
oriented thought. The choice of these factors was based on the variables 
most frequently reported as overlapping in many studies about alcohol 
and drug abuse/dependence. Unlike those studies that were mainly 
descriptive, the present research provides an exploratory regressive 
model of cannabis abuse. 
Our preliminary results are consistent with the [25,45] studies that 
found 30% alexithymia among cannabis abusers and 36% alexithymia 
among cannabis-dependent participants. In the present study, 36.1% of 
participants with high risk for cannabis abuse were revealed to be also 
alexithymic. Furthermore [45], observed that 58% of their alexithymic 
participants were depressed (mildly and moderately). Accordingly, 47% 
of the present study’s participants were found to be depressed (mildly 
and moderately). According to the literature, despite using different 
depression assessment scales (Beck Depression Inventory in [45], these 
is possible to select, either by deletion or inclusion, the most relevant 
explanatory variables of cannabis abuse by conducting a stepwise 
technique based on the Akaike Information Criterion (AIC). The 
retained best model was reported in Table 4. This model included only 
the three reliable factors: anxiety (p<.005), depression (p=.005) and 
difficulty describing feelings (p<.05). According to the odds ratios of 
the final model, 54.3% of anxious individuals are likely to be individuals 
with high risk for cannabis abuse relative to 55.1% of depressive 
individuals and 21.8% of individuals with difficulty describing feelings. 
Figure 2 shows the curves of the regression effects for the three factors; 
it can be seen that difficulty describing feelings showed a less sigmoidal 
shape compared to anxiety and depression, which suggests that its 
statistical significance in the retained model is likely to be at some point 
mediated by anxiety and depression (Appendix 1).
Additive vs. Interactive regression models comparison
In order to assess a potential contributing effect of any interaction between 
the three retained factors, we compared in Table 5, all possible interaction 
models derived from the three variables against M1, the additive model reported 
in Table 4. None of the interaction terms in the four multiplicative models was 
significant (ps>.1) and is indicated by higher AIC values compared to M1, 
which showed the lowest AIC and consequently is the more parsimonious 
model. This latter comparison is crucial to demonstrate that anxiety, depression 
and difficulty describing feelings do not interact between each other to explain 
high-risk cannabis abuse. 
Mean sd Min - Max Skew Kurtosis
Anxiety 8.16 3.61 1 - 19 0.71  0.11
Depression 3.84 3.72 0 - 14 1.07 -0.22
DDF 12.05 4.58 5 - 25 0.62 -0.05
DIF 15.77 6.24 7 - 32 0.81 -0.20
EOT 15.65 3.69 8 - 26 0.12 -0.59
Table 2: Descriptive statistics summary related to the five continuous predictors in 
the regression model.
 
Figure 1: Strip chart graphic representing the discrete distributions of the five 
predictors in the initial model as a function of cannabis addiction (addicted 
vs. control). The dashed lines represent the means of the variables for all 
participants.
Factor β value P value Odds ratio
Intercept -22.5 .002 1.7 e-10
Anxiety 1.26** .01 3.7
Depression 1.21* .02 3.5
DDF 0.26 .09 1.3
DIF 0.10 .62 1.1
EOT 0.25 .20 1.3
Table 3: Multiple logistic regression coefficients and odds ratios (ODs) for the initial 
additive model including five predictors.
Factor β value P value Odds ratio
Intercept -17.07 0.0002 3.8 e-08
Anxiety 1.19 0.0015 3.318125
Depression 1.23 0.0050 3.428422
DDF 0.28 0.0450 1.332158
Table 4: Multiple logistic regression coefficients and odds ratios (ODs) for the best 
model after a stepwise procedure.
 
Figure 2: The graphical representation of the logistic regression effects curves 
with plus or minus confidence interval (dashed lines) for the three predictors 
in the retained model. Anxiety and depression in the upper panels and DDF in 
the lower panel. Note that sigmoidal shape is more obvious with anxiety and 
depression and less obvious with DDF. 
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proportions were about the same.
The present study showed that only anxiety, depression, and 
difficulty in describing feelings were retained in the final regression 
model. This is consistent with what has been argued by [26,27] 
concerning the robust relationship between anxious and depressive 
symptoms and higher risk of substance abuse and dependence in 
adolescents and young adults. More important is that this relationship 
was also observed with heavy users of cannabis [28,25] speculated 
that the relationship between cannabis addiction and anxiety may be 
caused by another risk factor such as personality traits disorders. The 
present study went beyond [45] interpretation and we gave a broader 
account for risk factors. The relationship between depression, anxiety, 
and alexithymia is controversial: for some authors both anxiety and 
depression can be explained by alexithymia [60,61] while for others 
alexithymia is explained by anxiety and depression [62,63]. However, 
depression, anxiety, and alexithymia can be also distinct constructs 
or separate dimensions reinforcing each other [64]. This statement is 
supported by the lack of fit of all the multiplicative models (including all 
the two-way and the three-way interaction terms) of interaction tested 
in this study, in comparison to the additive model that was retained. 
However, the regression model cannot further explain the direction of 
the causal relationship between cannabis abuse and the studied factors. 
In fact, cannabis use could reversely promote anxious and depressive 
symptoms as stated by some authors [6]. Anxiety was revealed to be a 
major factor of cannabis abuse in our study. This result is in line with 
previous findings that reported high levels of anxiety among cannabis 
users as a linear function of use, abuse, and dependence [28,65]. Finally, 
self-medication and cannabis use is another aspect worthy of mention 
to further explain the primary effect of anxiety in the regression model. 
Indeed [66], showed that individuals with high levels of anxiety tend 
to use cannabis in order to self-medicate their anxious symptoms. This 
contributing factor is likely to be observed within a normal population 
that attributes addictive behavior to a self-medication purpose [62]. 
Despite its explanatory nature, the present study provided a preliminary 
description of the most relevant psychological factors that may explain 
cannabis abuse. Follow-up studies will shed more light on other factors 
that can potentially predict cannabis abuse, such as coping mechanisms, 
quality of life, and well-being. 
Possible contribution of the research to health policy
In France, heavy users (abuse and dependence) of cannabis are 
welcomed in health centers, support and addictology prevention 
programs. These centers have outpatient consultations in addiction 
or in general practice. The country has witnessed in the recent years 
a growing awareness of the implications for public health of the 
widespread and long-term consumption of this substance. This 
awareness has led to an increase in the number of care demands for 
cannabis-related problems. However, improving the governance of 
public policy in the fight against drugs and addictive behavior implies 
the need for scientifically validated data. The latter are useful to the 
development of public policies that are more effective in providing 
health professionals dealing with teenagers and young adults with 
critical cannabis use, with tools for prevention when they directly deal 
and, identifying and taking health and psychosocial therapy. Hence, 
the quantitative psychopathology of addictive behavior such as the 
approach presented in the current study has the potential to identify 
certain risk factors or psychological vulnerability towards cannabis 
abuse and dependence. The most identified risk factors refer to anxiety, 
depression and emotional disorders, including alexithymia that play the 
role of behavioral indicators of heavy addiction problems [26]. 
Limits and perspectives 
One limitation of this study is the small sample size. Only 35 
individuals who met the criteria of the CAST scale were selected 
from an initial sample of 268 participants. They were considered as 
individuals with high risk for cannabis abuse. A larger sample would 
allow comparisons between men vs. women and a more robust 
“generalization” of the obtained results. Indeed, gender can be a 
potential confounding factor and the unequal sex ratio in the present 
study stemmed from the fact that the chosen population was psychology 
students. In France, this population is largely female. Gender can be 
a detrimental variable, especially in relation with the description of 
emotions. Future studies must explore the role of gender in high risk 
for cannabis abuse.
Another limitation is the nature of the assessment tools. In France, 
the use of cannabis is illegal, so it is likely that part of the participants 
have downplayed or omitted their consumption and are therefore 
considered non-abusers. The self-report tools have the advantage 
of speed and ease to obtain data, but they have the disadvantage of 
somehow biasing the diagnosis due to the participants’ subjective 
judgments such as their emotions and attitudes. One may ask, how an 
alexithymic person unable to express his/her own emotions can report 
responses related to his/her depressive or anxious states. This issue is 
paramount as long as alexithymia is assumed from a typological (or 
categorical) perspective. 
However, in the present study all the measuring scales are based 
on participants’ self-reports, including the HAD and the TAS-20 and 
alexithymia was considered from a dimensional perspective (in terms 
of continuity and severity). The concept of alexithymia has been 
operationalized with many dimensions and the TAS-20 is among 
the most used self-report tools. Nevertheless, it seems imperative to 
combine for future studies self-assessment methods with observers’ 
reports also referred to as hetero-assessment (e.g., by using Mini 
International Neuropsychiatric Interview). Accordingly, by replicating 
this study in health care institutions with in-patients and out-patients 
based on a psychiatric diagnosis where anxiety and depression would 
be treated as typological variables, data from patients and participants 
Model expression DF residual d e v i a n c e residuala DF Deviance AIC
b
M1. addiction = anxiety + depression + DDF 91 26.10 34.10
M2. addiction = anxiety + depression + DDF + (anxiety x depression) 90 26.01 1 0.08767 36.01
M3. addiction = anxiety + depression + DDF + (anxiety x DDF) 90 25.01 0 1.00524 35.01
M4. addiction = anxiety + depression + DDF + (depression x DDF) 90 25.62 0 -0.61127 35.62
M5. addiction = anxiety + depression + DDF + (anxiety x depression x DDF) 87 24.72 3 0.90067 40.72
Table 5: Model comparisons between the additive model, M1. and 4 multiplicative models (M2, M3, M4 & M5) based on residual deviance parameter and AIC value as 
goodness of fit measures.
a Observations with a deviance residual in excess of two may indicate lack of fit.
b Akaike Information Criterion calculated by the following formula: 2 k - 2 ln(L) with k being the number of parameters in the model and L being the maximized log-likelihood 
of the estimated model.
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of a general population can be directly compared.
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